An open-label trial of adjunctive oxcarbazepine for bipolar disorder.
Conway
Charles R
CR
Chibnall
John T
JT
Nelson
Leigh Anne
LA
McGuire
J Michael
JM
Abraham
Praveen F
PF
Baram
Vadim Y
VY
Grossberg
George T
GT
Carroll
Bernard J
BJ
D000927:Anticonvulsants / Q000627:therapeutic use*; D000928:Antidepressive Agents / Q000627:therapeutic use; D018692:Antimanic Agents / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy*; D002220:Carbamazepine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D000078330:Oxcarbazepine; D010865:Pilot Projects; D011569:Psychiatric Status Rating Scales; D016896:Treatment Outcome
D000927:Anticonvulsants; D000928:Antidepressive Agents; D018692:Antimanic Agents; D002220:Carbamazepine; D000078330:Oxcarbazepine